We were proud to take part in the official launch of the 2025 Catalyser programme
May 19, 2025
Pharmidex is excited to support this incredible initiative, which welcomes 8 promising therapeutics companies at (or near) the pre-clinical stage.
Over the next 8 weeks, they’ll sharpen their strategy using the Triple Chasm framework and gain access to a powerful mix of scientific, business, and communication support.
During the launch, our very own
Ash Alavijeh joined
Prabhu Velusami, MD (Johnson & Johnson) and
Daniel Marshall (MSD) in a panel discussion exploring trends and opportunities in the therapeutics landscape.
It was a brilliant exchange of insights that inspired the cohort and sparked new conversations.
As part of the Catalyser package, we’re proud to offer:
π¬ Complimentary CRO services from Pharmidex
π€ AI innovation support with Asae Biotechnology Consulting
π€ 1:1 storytelling coaching with
Kat Arney
from First Create The Media
Huge thanks to Hertfordshire Futures and Stevenage Bioscience Catalyst for driving this programme and for the opportunity to collaborate with such a forward-thinking ecosystem!


Join our Bioanalysis Group to advance drug discovery! π¬ Role: - LC-MS/MS analysis in biological matrices - Method development/validation - Sample prep & study support - Ensure data quality π‘ You need: - BSc/MSc (Chemistry/Biochemistry) - LC-MS/MS experience - GLP/GCP knowledge - Problem-solving skills π We offer: - Competitive salary + pension - Training & growth - Life insurance, perks, parking π§ Apply: CV to [email protected]

At Pharmidex , we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration. π Scientist-Led from Start to Finish Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution. π€ Connected Teams, Coordinated Delivery From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication. π§ͺ Agile, High-Quality Science We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency. π§ We’re Not Just a CRO, We’re Your Partner We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission. Let’s partner on your next breakthrough. π§ Contact us today.